Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts

INTRODUCTION: Gender-specific differences have led to the androgen receptor (AR) being considered a possible factor in the pathophysiology of urothelial carcinoma of the bladder (UCB), but the exact role remains unclear. MATERIALS AND METHODS: The association of AR mRNA expression with clinicopathol...

Full description

Bibliographic Details
Main Authors:	Danijel Sikic, Ralph M. Wirtz, Sven Wach, Lars Dyrskjøt, Philipp Erben, Christian Bolenz, Johannes Breyer, Wolfgang Otto, Katherine A. Hoadley, Seth P. Lerner, Markus Eckstein, Arndt Hartmann, Bastian Keck
Format:	Article
Language:	English
Published:	Elsevier 2019-04-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523318306478

Similar Items

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
by: Danijel Sikic, et al.
Published: (2021-06-01)

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
by: Danijel Sikic, et al.
Published: (2017-06-01)

mRNA-Expression of <em>KRT5</em> and <em>KRT20</em> Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
by: Markus Eckstein, et al.
Published: (2018-10-01)

Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
by: Arndt Hartmann, et al.
Published: (2020-06-01)

Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
by: Jennifer Kubon, et al.
Published: (2020-09-01)

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
by: Veronika Weyerer, et al.
Published: (2021-05-01)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
by: Danijel Sikic, et al.
Published: (2020-04-01)

Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
by: F. Roghmann, et al.
Published: (2020-07-01)

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
by: Danijel Sikic, et al.
Published: (2017-01-01)

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
by: M.C. Kriegmair, et al.
Published: (2018-04-01)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
by: Sikic D, et al.
Published: (2021-08-01)

Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy
by: Helge Taubert, et al.
Published: (2021-01-01)

The Role of Androgen Receptor in Upper Urinary Tract Urothelial Cancer and Target for Treatment
by: Chi-Cheng Chen, et al.
Published: (2017)

Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
by: Veronika Weyerer, et al.
Published: (2020-03-01)

Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder
by: Maria V. Luna‐Velez, et al.
Published: (2021-07-01)

ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
by: Satoshi Inoue, et al.
Published: (2018-11-01)

Evaluation of androgen receptor status in urothelial carcinoma of the urinary bladder in Egyptian patients: an immunohistochemical study
by: Mohamed Wagih, et al.
Published: (2020-01-01)

Androgen Receptor Is a Potential Therapeutic Target for Upper Urinary Tract Urothelial Cell Carcinoma
by: Teng-Fu Hsieh, et al.
Published: (2013)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
by: Rui Zhu, et al.
Published: (2019-10-01)

Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients
by: Paul König, et al.
Published: (2020-09-01)

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
by: Hendrik Jütte, et al.
Published: (2021-05-01)

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
by: Keck Bastian, et al.
Published: (2013-02-01)

Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial carcinoma cells
by: Chi-Cheng Chen, et al.
Published: (2015-06-01)

Prognostic Effects and Regulation of Activin A, Maspin, and the Androgen Receptor in Upper Urinary Tract Urothelial Carcinoma
by: Kun-Ming Rau, et al.
Published: (2012)

Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients
by: Markus Eckstein, et al.
Published: (2021-07-01)

<i>TERT</i> Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers
by: Veronika Weyerer, et al.
Published: (2021-02-01)

CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
by: Markus Eckstein, et al.
Published: (2020-05-01)

A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer.
by: Daniel Uysal, et al.
Published: (2021-01-01)

Expression of components of the urothelial cholinergic system in bladder and cultivated primary urothelial cells of the pig
by: Dorothea Leonhäuser, et al.
Published: (2019-07-01)

Prenatal androgen induced lean PCOS impairs mitochondria and mRNA profiles in oocytes
by: Neil R Chappell, et al.
Published: (2020-03-01)

Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions
by: Bastian Keck, et al.
Published: (2021-05-01)

Detection of Androgen Receptor Variant 7 (<i>ARV7)</i> mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
by: Claudia Hille, et al.
Published: (2019-09-01)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
by: Sebastien Rinaldetti, et al.
Published: (2020-11-01)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
by: Sindhu Govindan, et al.
Published: (2020-08-01)

A smart deoxyribozyme-based fluorescent sensor for in vitro detection of androgen receptor mRNA
by: Ekaterina A. Bryushkova, et al.
Published: (2020-05-01)

The Role of Fibroblast Growth Factor Receptor 3 (FGFR3) and Androgen Receptor (AR) in a Non-invasive Urothelial Carcinoma Recurrences
by: Oki Meilani Dewi, et al.
Published: (2019-08-01)

The prognostic significance of androgen receptor and β-catenin immunohistochemical expression in urothelial carcinoma with and without detrusor muscle invasion from an Egyptian institution
by: Shaimaa Elzamy, et al.
Published: (2018-11-01)

Effect of CYP3A Single Nucleotide Polymorphism on Nifedipine Pharmacokinetics and Effect of Androgen Receptor Length Polymorphism on Urothelial Carcinogenesis in Chinese
by: Chin-Hung Liu, et al.
Published: (2007)

Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells
by: Felix Wezel, et al.
Published: (2021-03-01)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
by: Shtutman Michael, et al.
Published: (2010-04-01)